(2012). Cervical cancer cell lines expressing NKG2Dligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology, 13(1), 7. https://doi.org/10.1186/1471-2172-13-7
Chicago Style (17th ed.) Citation"Cervical Cancer Cell Lines Expressing NKG2Dligands Are Able to Down-modulate the NKG2D Receptor on NKL Cells with Functional Implications." BMC Immunology 13, no. 1 (2012): 7. https://doi.org/10.1186/1471-2172-13-7.
MLA (9th ed.) Citation"Cervical Cancer Cell Lines Expressing NKG2Dligands Are Able to Down-modulate the NKG2D Receptor on NKL Cells with Functional Implications." BMC Immunology, vol. 13, no. 1, 2012, p. 7, https://doi.org/10.1186/1471-2172-13-7.
Warning: These citations may not always be 100% accurate.
